Cargando…
From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
Hypertension is a major risk factor for stroke, coronary events, heart and renal failure, and the renin-angiotensin system (RAS) plays a major role in its pathogenesis. Within the RAS, angiotensin converting enzyme (ACE) converts angiotensin (Ang) I into the vasoconstrictor Ang II. An “alternate” ar...
Autores principales: | Patel, Sheila K., Velkoska, Elena, Freeman, Melanie, Wai, Bryan, Lancefield, Terase F., Burrell, Louise M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067757/ https://www.ncbi.nlm.nih.gov/pubmed/25009501 http://dx.doi.org/10.3389/fphys.2014.00227 |
Ejemplares similares
-
The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation
por: Lancefield, Terase F., et al.
Publicado: (2016) -
Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition
por: Burrell, Louise M., et al.
Publicado: (2017) -
Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition
por: Velkoska, Elena, et al.
Publicado: (2009) -
Short-Term Treatment with Diminazene Aceturate Ameliorates the Reduction in Kidney ACE2 Activity in Rats with Subtotal Nephrectomy
por: Velkoska, Elena, et al.
Publicado: (2015) -
Left ventricular hypertrophy in experimental chronic kidney disease is associated with reduced expression of cardiac Kruppel-like factor 15
por: Patel, Sheila K., et al.
Publicado: (2018)